Hakutulokset - Felix Agbo

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors Tekijä Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz

Hae kokoteksti